Curriculum vitae

Main Research Areas
  • Infection biology of human pathogenic fungi (especially Candida albicans)
  • Infection biology of Neisseria meningitidis
Professional Career
Since 2017 Chair of Medical Microbiology and Mycology, Institute for Hygiene and Microbiology, Julius Maximilians University Würzburg and head of the research group Fungal Septomics at Leibniz Institute for Natural Product Research and Infection Biology – Hans-Knöll-Institute Jena
2009-2016 Professor (W2) for Fungal Septomics, Friedrich-Schiller-University Jena
2008 Habilitation in medical microbiology, University Würzburg
2006 Medical specialist in microbiology, virology and infection epidemiology (Bayerische Landesärztekammer)
2003 Head of a working group, Institut für Hygiene und Mikrobiologie, University Würzburg
2001-2002 Doctor in practical training (AiP), Institut für Hygiene und Mikrobiologie, University Würzburg
2002 Dr. med., “summa cum laude” University Würzburg
2001 Staatsexamen (state examination) in human medicine, University Würzburg
Awards · Appointments · Scientific Activities
Since 2014 Head of the Nationales Referenzzentrums für invasive Pilzinfektionen (NRZMyk)
Since 2013 Board member of the Integriertes Forschungs- und Behandlungszentrum “Center for Sepsis Control and Care” (CSCC) at the University Hospital Jena
Since 2012 Scientific Manager of the consortium “InfectControl 2020 – New Antiinfection Strategies – Science • Society • Economy” within the BMBF-Programme “Zwanzig 20 – Partnership for Innovation” (Head: Prof. A. Brakhage)
Since 2012 Editor-in-chief, Medical Mycology Case Reports, member (ex officio) of the executive board of the International Society for Human & Animal Mycology (ISHAM)
Since 2011 Elected note taker at the Deutschsprachige Mykologische Gesellschaft DMykG
2015-2016 Speaker of the ZIK Septomics
2011-2013 Editor, Journal of Basic Microbiology
2009 Hans-Rieth-poster prize from the Deutschsprachige Mykologische Gesellschaft (DMykG)
2008 Award from the Deutsche Gesellschaft für Hygiene und Mikrobiologie
2003 Science award from the Unterfränkische Gedenkjahrstiftung
2003 Dissertation award from the medical faculty of the University Würzburg
2002 Becton-Dickinson PhD award from the Deutsche Gesellschaft für Hygiene und Mikrobiologie

Publications

Springer J, Walther G, Rickerts V, Hamprecht A, Willinger B, Teschner D, Einsele H, Kurzai O, Loeffler J (2019) Detection of fusarium species in clinical specimens by probe-based real-time PCR. J Fungi (Basel) 5(4), 105.
Vivas W, Leonhardt I, Hünniger K, Häder A, Marolda A, Kurzai O (2019) Multiple signaling pathways involved in human dendritic cell maturation are affected by the fungal quorum-sensing molecule farnesol. J Immunol 203(11), 2959-2969.
von Lilienfeld-Toal M, Wagener J, Einsele H, Cornely OA, Kurzai O (2019) Invasive fungal infection. Dtsch Arztebl Int 116(16), 271-278. (Review)
Wagener J, Kurzai O (2019) Candida auris – Steckbrief eines neuen Pilzes. Deutsches Ärzteblatt Suppl. Perspektiven der Infektiologie & Immunologie 116(1), 29-30. (Review)
Wagner L, de Hoog S, Alastruey-Izquierdo A, Voigt K, Kurzai O, Walther G (2019) A revised species concept for opportunistic Mucor species reveals species-specific antifungal susceptibility profiles. Antimicrob Agents Chemother 63(8), e00653-19.
Wagner L, Stielow JB, de Hoog GS, Bensch K, Schwartze VU, Voigt K, Alastruey-Izquierdo A, Kurzai O, Walther G (2019) A new species concept for the clinically relevant Mucor circinelloides complex. Persoonia - Molecular Phylogeny and Evolution of Fungi 42, 67-97.
Walther G, Wagner L, Kurzai O (2019) Updates on the taxonomy of mucorales with an emphasis on clinically important taxa. J Fungi (Basel) 5(4), 106. (Review)
Walther G, Wagner L, Kurzai O (2019) Outbreaks of mucorales and the species involved. Mycopathologia 185(5), 765-781. (Review)
Zoran T, Weber M, Springer J, White PL, Bauer J, Schober A, Löffler C, Seelbinder B, Hünniger K, Kurzai O, Scherag A, Schäuble S, Morton CO, Einsele H, Linde J, Löffler J (2019) Treatment with etanercept and low monocyte concentration contribute to the risk of invasive aspergillosis in patients post allogeneic stem cell transplantation. Sci Rep 9(1), 17231.
Bloos F, Held J, Schlattmann P, Brillinger N, Kurzai O, Cornely OA, Thomas-Rüddel D (2018) (1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with sepsis and with an increased risk of invasive Candida infection (CandiSep): Study protocol for a randomized controlled trial. Trials 19(1), 472.